Why Is Leucovorin Out of Stock? Inside the 2026 Shortage

Families on a leucovorin trial in 2026 have been running into the same wall at retail pharmacies across the country: “We’re out, and we don’t know when we’ll have it back.” The shortage is real, it has been ongoing through much of 2026, and it has hit families in the autism, cerebral folate deficiency, and oncology communities particularly hard.

This article covers what is happening, why, and the practical question every family on leucovorin needs answered: where do I get the medication if my regular pharmacy is empty?

What Is Actually Going On With the Supply?

Leucovorin (folinic acid, calcium folinate) has been on shortage status with the FDA on and off through 2024-2026. The 2026 wave has been the longest and most disruptive since the medication’s modern history. Multiple factors have stacked:

• Manufacturer consolidation. A small number of manufacturers globally produce generic leucovorin tablets. When one supplier has a production issue, the entire downstream supply tightens because there is no extra capacity in the system.
• API (active pharmaceutical ingredient) availability. Manufacturers source folinic acid API internationally, and supply chain disruptions earlier in 2025-2026 reduced the inflow.
• Surge in off-label demand. The growth of leucovorin use in pediatric autism and cerebral folate-related conditions has added meaningful new demand on top of the existing oncology baseline.
• Manufacturing prioritization. When supply tightens, manufacturers tend to prioritize injectable forms used in oncology over oral tablets used in outpatient psychiatric and developmental settings, which is where most autism families fill prescriptions.

The end result has been intermittent stockouts at retail chain pharmacies (CVS, Walgreens, Rite Aid) and slower restocking cycles. Some independent pharmacies and compounding pharmacies have weathered the shortage better than the national chains because they buy through different distributors.

Why Is This Hitting Las Vegas Families Particularly Hard?

Two reasons. First, Las Vegas does not have a large network of compounding pharmacies that specialize in pediatric formulations — fewer fallback options when retail chains run out. Second, the autism and cerebral folate communities in southern Nevada have grown faster than local pharmacy stock has kept up with, so even the pharmacies that have leucovorin available do not always have enough.

The practical effect: a family who fills their prescription at a chain pharmacy may run into a 1-3 week stockout, sometimes longer. For pediatric patients on a continuous trial, that gap can be enough to confuse the picture of whether the medication is working.

What to Do When Your Pharmacy Is Out

The single most useful skill during a shortage is calling multiple pharmacies and asking the right question. “Do you have leucovorin in stock?” is too vague — pharmacies often have one strength and not another, or have it in injectable form but not oral, or have a brand version but not the generic the prescriber wrote on the script.

The better question is: “Do you have leucovorin calcium [strength] [oral tablet/IV] from [manufacturer/NDC if known] in stock right now?” Pharmacy techs can check this in their system in under a minute when given the specific information.

The fallback path most clinicians use:

1. Call the original pharmacy. Ask for the date they expect restock. Sometimes it is 3-5 days, in which case the simplest answer is to wait.
2. Try 3-5 nearby pharmacies. Mix of chains and independents. Ask about specific strengths and forms, not “leucovorin in general.”
3. Reach out to a compounding pharmacy. Las Vegas has several. Compounded leucovorin is more expensive but usually available when retail is empty.
4. Ask the prescriber to switch the prescription. If a different strength is in stock somewhere, the provider can adjust the prescription to match — for example, two 5 mg tablets instead of one 10 mg tablet, if 10 mg is unavailable but 5 mg is in stock.
5. Check oncology pharmacies. Pharmacies attached to cancer-care infrastructure sometimes have stock when general retail does not, particularly for the injectable form.

For first-time fills, this whole process gets easier when the prescriber has already mapped which pharmacies have current stock. Considering leucovorin as a structured trial means thinking about pharmacy access alongside the medical decision.

Compounding Pharmacies — When Do They Make Sense?

Compounding pharmacies prepare medications individually rather than dispensing pre-manufactured tablets. For leucovorin, compounding usually means an oral suspension or a custom-strength capsule. The advantages during a shortage:

• Stock is not tied to the same distribution channels that fail during a national shortage
• Custom strengths are possible — useful when standard-dose tablets are unavailable
• Liquid formulations are easier for younger children who cannot swallow tablets

The trade-offs:

• Cost is typically higher than retail (often 1.5-3× the retail rate)
• Insurance coverage for compounded medications is more variable than for standard prescriptions
• No one has formally established bioequivalence to the FDA-approved tablets for every compounded preparation, so the prescribing provider should approve the switch

Most prescribers in Las Vegas have a relationship with one or two compounding pharmacies they trust. Ask them where to send the prescription rather than picking randomly.

Switching Forms or Strengths — When Is It Safe?

Switching strengths is usually fine as long as you preserve the daily total dose. Changing forms (oral to IV, IV to oral, tablet to liquid suspension) is more involved and should always go through the prescribing provider because absorption profiles can differ.

One specific switch families sometimes ask about: methylated folate (5-MTHF) supplements as a substitute for leucovorin during a shortage. The two are not interchangeable. Leucovorin (folinic acid) bypasses the folate receptor blockade in cerebral folate dysfunction; methylated folate does not, and in some patients can actually worsen symptoms. If the prescribing provider is recommending a methylated folate supplement during a leucovorin gap, follow that direction. If a family is improvising on their own, that is a reason to call the provider first.

How Long Will the Shortage Last?

Honest answer: nobody outside the manufacturers knows. FDA shortage timelines are notoriously hard to predict — supply often returns 2-4 weeks before the FDA updates the database entry, and shortages sometimes resolve and reappear within the same year. Watching the FDA Drug Shortages database and the ASHP shortage list is the most reliable way to get current status. Local pharmacies often have better real-time information than the federal database, so calling around still beats relying on the website alone.

Should I Stockpile?

Generally no. Leucovorin tablets have a defined shelf life and stockpiling more than a 60-90 day supply is rarely useful. Some prescribers will write a 90-day supply during a shortage if the patient and pharmacy can support it. Beyond that, the math stops favoring stockpiling — by the time a 6-month supply is finished, either the shortage will have resolved or the dose may have changed.

The exception: if a specific strength or formulation is hard to find in your area, getting a 90-day supply when stock is available is reasonable. Talk to the prescriber about extending the prescription duration if the next refill is at risk.

What If My Child Has Already Started a Trial and Now Cannot Continue?

This is the most stressful scenario. A child started leucovorin, was responding (or might have been responding — the picture was still unclear), and the pharmacy ran out. What to do:

• Pause is usually clinically tolerable. A 1-3 week gap will not undo whatever response was building, but it may temporarily soften the gains. Most response patterns reassert themselves quickly when the medication restarts.
• Document the pause. Note when the medication stopped, any behavioral changes during the gap, and when it restarted. This information is useful for the provider trying to interpret the response trajectory.
• Call the prescriber. Some practices keep a small reserve supply for established patients during shortage gaps, or have specific compounding partners who can fill on short notice.
• Avoid restarting at full dose if the gap was longer than 4 weeks. Sometimes a re-titration is helpful, particularly if the original starting dose produced significant activation.

Frequently Asked Questions

How long has the leucovorin shortage been going on?

The FDA database has listed intermittent shortages since 2024. The 2026 wave intensified in early-to-mid 2026 and has continued at varying severity. Always check the FDA Drug Shortages database for current status before assuming any specific window.

Can I substitute methylated folate (5-MTHF) for leucovorin?

Not without the prescriber’s input. The two work through different pathways and are not interchangeable in cerebral folate dysfunction. In some patients, methylated folate can worsen symptoms. Always confirm with the prescriber before switching.

Do compounding pharmacies always have leucovorin?

Generally yes during national retail shortages, but stock varies and prices are higher. Calling ahead to confirm before driving across town saves time.

Is the IV form easier to find than tablets?

Sometimes yes — the injectable form moves through different distribution channels and oncology infrastructure may have stock when general retail does not. Switching from oral to IV is a clinical decision, though, not a logistics shortcut, so it has to go through the prescriber.

Will my insurance still cover compounded leucovorin?

Variable. Some plans cover compounded prescriptions when the manufactured form is on official shortage; some require pre-authorization; some deny. Call the pharmacy benefits manager directly or ask the compounding pharmacy’s billing team — they handle this question often.

What if I can’t find leucovorin anywhere?

Call the prescribing provider. Most have working relationships with at least one pharmacy that can fill, and during long shortages they sometimes adjust the dose or schedule to stretch existing supply until stock returns.

This article reflects the leucovorin supply situation as of mid-2026 and may be outdated by the time you read it. Always check the FDA Drug Shortages database for current status. Michael Kuron, MSN, APRN, PMHNP-BC is a board-certified psychiatric-mental health nurse practitioner serving the Las Vegas community.